Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|January 4, 2022
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 Omicron variantVenkata-Viswanadh Edara, Kelly E Manning, Madison Ellis, et al.
Immunity|February 25, 2021
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungsNanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2021
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cellsKristen W Cohen, Susanne L Linderman, Zoe Moodie, et al.
Research Square|May 20, 2021
Systems biological assessment of human immunity to BNT162b2 mRNA vaccinationPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Cell Host & Microbe|April 2, 2021
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2021
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variantVenkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Medrxiv : the Preprint Server for Health Sciences|January 12, 2022
Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concernRajesh Valanparambil, Jennifer Carlisle, Susanne Linderman, et al.
Nature|July 12, 2021
Systems vaccinology of the BNT162b2 mRNA vaccine in humansPrabhu S Arunachalam, Madeleine K D Scott, Thomas Hagan, et al.
Pageof 5